TCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 27, 2014
TCL Archive Commentary: NCI’s Budge Proposal ForFY2001 Offers A Blueprint for Research November 26, 1999